Literature DB >> 18213488

Overlap technique improves results of primary surgery after obstetric anal sphincter tear.

A Lepistö1, T Pinta, M-L Kylänpää, E Halmesmäki, T Väyrynen, A Sariola, V Stefanovic, A Aitokallio-Tallberg, V-M Ulander, P Molander, P Luukkonen.   

Abstract

PURPOSE: This study was designed to evaluate prospectively the results of the overlap technique in primary sphincter reconstruction after obstetric tear.
METHODS: Obstetric tears in 44 women were operated on with primary overlap reconstruction. These women were investigated six to nine months after the operation. Results were compared with those of a historical control group of 52 women whose obstetric sphincter rupture had been treated with the end-to-end technique.
RESULTS: The overlap group had significantly more incontinence symptoms after delivery and repair of the sphincter tear than before delivery (P < 0.0001); however, their incontinence symptoms were significantly fewer than those of the end-to-end group (P = 0.004). The prevalence of persistent rupture of the external anal sphincter was significantly lower in the overlap group (6/44, 13.6 percent) than in the end-to-end group (39/52, 75 percent; P < 0.0001). Internal anal sphincter rupture occurred in 5 patients (11.4 percent) in the overlap group and in 40 patients (76.9 percent) in the end-to-end group (P < 0.0001).
CONCLUSIONS: The overlap technique should be adopted as the method of choice for primary sphincter repair after obstetric tear.

Entities:  

Mesh:

Year:  2008        PMID: 18213488     DOI: 10.1007/s10350-007-9182-3

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  1 in total

1.  A modified surgical approach to women with obstetric anal sphincter tears by separate suturing of external and internal anal sphincter. A modified approach to obstetric anal sphincter injury.

Authors:  Pelle G Lindqvist; Mats Jernetz
Journal:  BMC Pregnancy Childbirth       Date:  2010-09-09       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.